Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,675.82
(
-0.60%
)
US TECH 100
24,032.40
(
-0.41%
)
Dow Jones
46,570.71
(
-0.90%
)
Brent Oil
105.41
(
4.72%
)
Bitcoin
71,287.74
(
-3.59%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mouton29

Send PM Follow Ignore
Followers 24
Posts 2251
Boards Moderated 0
Alias Born 04/14/2007

mouton29

Member Level

Re: biomaven0 post# 99841

Tuesday, 07/27/2010 11:58:53 AM

Tuesday, July 27, 2010 11:58:53 AM

Post# of 257253
<<It's tough to get a TRO.>>

Isn't 2 on your list -- no TRO if monetary damages suffice - the reason the generics can be launched "at risk", i.e., they pay damages if it turns out they are infringing the patent, instead of being enjoined? Or is that covered by specific legislation?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now